Alternative splicing is a process by which a single gene can produce multiple protein isoforms through the inclusion or exclusion of different exons during mRNA processing. This mechanism allows for increased protein diversity and functional complexity in cells. In the context of cancer, aberrant alternative splicing can lead to the production of protein variants that promote tumor growth, survival, and metastasis.
